Prognostic factors affecting survival and recurrence after hepatic resection for hepatocellular carcinoma in cirrhotic liver
- PMID: 20358380
- DOI: 10.1007/s00423-010-0643-0
Prognostic factors affecting survival and recurrence after hepatic resection for hepatocellular carcinoma in cirrhotic liver
Abstract
Aim: Hepatic resections for hepatocellular carcinoma (HCC) in cirrhotic liver are characterized by early recurrence and poor survival. In this study, we analyzed several factors affecting both survival and recurrence after hepatic resection.
Patients and methods: From October 1995 to April 2007, 550 patients underwent hepatic resections, of which, 175 patients had HCC in cirrhotic liver in Gastroenterology Surgical Center, Mansoura University, Egypt. There were 131 males (74.9%) and 44 females (25.1%) with a mean age of 54.8 +/- 9.2 years (ranges from 26 to 75 years).
Results: Most of our patients were in Child's Pugh class A (86.9%). Major hepatic resection was done for 65 patients (37.1%), segmentectomy was done for 62 patients (35.4%), and localized resection was done for 48 patients (27.4%). Hospital mortality occurred in 16 (9.1%) patients, while hospital morbidity occurred in 40% of patients. The 1, 3, and 5 years survival were 68.6%, 29.6%, and 10.7%, respectively. The prognostic factors affecting recurrence were multifactorial, and the univariate analysis showed that multifocality of the tumor (p = 0.006), capsule (p = 0.001), staging (p = 0.001), blood transfusion (p = 0.02), infiltration of the cut margin (p = 0.001), vascular invasion (p = 0.006), and lymph nodes infiltration (p = 0.014) affect the recurrence rate, while with multivariate analysis, only cut margin was significantly affecting the recurrence (p = 0.026). Also, factors that significantly predicted survival were preoperative serum albumin (p = 0.005), tumor differentiation (p = 0.008), staging (p = 0.001), tumor's capsule (p = 0.001), cut margin (p = 0.031), vascular invasion (p = 0.049), and operative blood transfusion (p = 0.001). However, tumor differentiation (p = 0.048) was the only independent factor on multivariate analysis affecting long-term survival.
Conclusion: In our experience, the prognostic factors after resection for recurrence and survival are different and multifactorial. However, resection of HCC in cirrhotic liver with preserved liver function is the treatment of choice in the present time and can be done with favorable results.
Similar articles
-
[Influence of cirrhosis on long-term outcomes after liver resection in patients with a single small hepatocellular carcinoma].Zhonghua Wai Ke Za Zhi. 2012 Oct;50(10):865-9. Zhonghua Wai Ke Za Zhi. 2012. PMID: 23302452 Chinese.
-
Minor versus major hepatic resection for small hepatocellular carcinoma (HCC) in cirrhotic patients: a 20-year experience.Surgery. 2010 May;147(5):676-85. doi: 10.1016/j.surg.2009.10.043. Epub 2009 Dec 11. Surgery. 2010. PMID: 20004441
-
Surgical management of hepatocellular carcinoma in Child-Pugh class B cirrhotic patients: hepatic resection and/or microwave coagulation therapy versus living donor liver transplantation.Ann Transplant. 2012 Dec 31;17(4):11-20. doi: 10.12659/aot.883689. Ann Transplant. 2012. PMID: 23274319
-
Prognostic factors of hepatic resection for hepatocellular carcinoma with cirrhosis: univariate and multivariate analysis.J Surg Oncol. 2002 Dec;81(4):195-202. doi: 10.1002/jso.10178. J Surg Oncol. 2002. PMID: 12451624 Review.
-
Liver resection for hepatocellular carcinoma in cirrhotic patients.Ital J Gastroenterol. 1992 Feb;24(2):105-10. Ital J Gastroenterol. 1992. PMID: 1315591 Review.
Cited by
-
The respiratory and hemodynamic effects of alveolar recruitment in cirrhotic patients undergoing liver resection surgery: A randomized controlled trial.J Anaesthesiol Clin Pharmacol. 2023 Jan-Mar;39(1):113-120. doi: 10.4103/joacp.joacp_188_21. Epub 2022 Apr 22. J Anaesthesiol Clin Pharmacol. 2023. PMID: 37250262 Free PMC article.
-
The impact of perioperative allogeneic blood transfusion on prognosis of hepatocellular carcinoma after radical hepatectomy: A systematic review and meta-analysis of cohort studies.Medicine (Baltimore). 2018 Oct;97(43):e12911. doi: 10.1097/MD.0000000000012911. Medicine (Baltimore). 2018. PMID: 30412094 Free PMC article.
-
Preoperative ultrasound features as prognostic factors for patients with hepatocellular carcinoma.Radiol Med. 2015 Jun;120(6):504-10. doi: 10.1007/s11547-014-0491-z. Epub 2015 Jan 9. Radiol Med. 2015. PMID: 25572544
-
Nuclear expression of the deubiquitinase CYLD is associated with improved survival in human hepatocellular carcinoma.PLoS One. 2014 Oct 16;9(10):e110591. doi: 10.1371/journal.pone.0110591. eCollection 2014. PLoS One. 2014. PMID: 25329885 Free PMC article.
-
The Histologic Cut-off Point for Adjacent and Remote Non-neoplastic Liver Parenchyma of Hepatocellular Carcinoma in Chronic Hepatitis B Patients.Korean J Pathol. 2012 Aug;46(4):349-58. doi: 10.4132/KoreanJPathol.2012.46.4.349. Epub 2012 Aug 23. Korean J Pathol. 2012. PMID: 23110027 Free PMC article.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous